Commentary on: Padeliporfin Vascular-targeted Photodynamic Therapy Versus Active Surveillance in Men With Low-risk Prostate Cancer (CLIN1001 PCM301): An Open-label, Phase 3, Randomized Controlled Trial

Urology. 2017 Jun:104:7-8. doi: 10.1016/j.urology.2017.03.020. Epub 2017 Mar 22.
No abstract available

Publication types

  • Letter
  • Multicenter Study

MeSH terms

  • Bacteriochlorophylls / administration & dosage*
  • Biopsy
  • Disease Progression
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Photochemotherapy / methods*
  • Photosensitizing Agents / administration & dosage
  • Prostate / diagnostic imaging
  • Prostate-Specific Antigen / blood
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / radiotherapy*
  • Randomized Controlled Trials as Topic
  • Risk
  • Time Factors
  • Treatment Outcome

Substances

  • Bacteriochlorophylls
  • Photosensitizing Agents
  • palladium-bacteriopheophorbide
  • Prostate-Specific Antigen